Axsome Therapeutics (NASDAQ:AXSM) Stock Price Expected to Rise, Mizuho Analyst Says
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price raised by research analysts at Mizuho from $137.00 to $195.00 in a report released on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho’s price target suggests a potential upside of 48.23% from the company’s previous close. Other equities analysts […]
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price raised by research analysts at Mizuho from $137.00 to $195.00 in a report released on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho’s price target suggests a potential upside of 48.23% from the company’s previous close. Other equities analysts […]
